The FTSE 100 managed to pull back some of yesterday's losses thanks to a rally and an 11-month high in GlaxoSmithKline's share value and a weakening of sterling against the dollar, and all despite a 27% loss in Jarvis' share value.
The FTSE 100 index closed up just over 20 points or 0.5% to 4505.5 by close of business in London, as rumours of a potential rate rise in the US strengthened the dollar to its best position in a year against sterling. It’s the large pharmaceutical firms such as GSK and AstraZeneca which have most to gain from an improvement in US sales, as the bulk of its profit originates in the US and financial reporting is conducted in US dollars. The pound today weakened to $1.7798 having yesterday closed the day at $1.7898 against the pound, but this is a stark improvement to the $1.7764 to the p...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes